ERBB2 and breast cancer: Using an in vitro generated HER2-overexpressed EGFR+ cell line model, this study found that several cytokines, such as CCL2, were increased by HER2 overexpression, leading to a pro-tumoral microenvironment through the CCL2-mediated trafficking of TAMs in breast cancer.